Renewed multi-year partnership to support Ferring Pharmaceuticals' operations in response to rapid business growth NEW YORK, Nov. 21, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced the extension of its partnership with Ferring Pharmaceuticals, a research-driven biopharmaceutical company that has operating subsidiaries in more than 50 countries and markets its medicines in over 100 countries. The renewed mul ...